Header Image

PCOS

Polycystic Ovarian Syndrome (PCOS) is a metabolic syndrome and state of hormonal imbalance. It is a condition in which cysts are formed in the ovaries due to the production of excessive androgens (male hormones). It is one of the most common endocrine disorders in females of reproductive age worldwide. Stein and Leventhal first described the disease in 1935. Though the prevalence of PCOS is high, it is underdiagnosed. It usually takes more than a year to get identified. This delay can lead to the progression of severe comorbidities.

Figure 1. Comparison of normal ovary and polycystic ovary


Symptoms of PCOS can begin as early as the time of the first menstrual period. 

Development of the symptoms of PCOS is most common in the reproductive age.


  1. Irregular periods:  Condition of not having periods at all for many days or having periods that last for many days. 
  2. Excess androgen: High levels of androgens result in excess facial and body hair. The condition is called hirsutism. This sometimes leads to excessive acne and male-patterned baldness as well. 
  3. Polycystic ovaries. The ovary size and volume increase. Cysts containing immature eggs are formed along the edges of the ovaries.

Causes

The aetiology of PCOS is unknown. Factors that might play a role include:

  1. Insulin resistance : Insulin is a hormone produced by the pancreas that helps the cells consume sugar. The level of blood sugar increases if the cells become resistant to insulin activity. As a result, more insulin is produced. Too much insulin might cause the body to make too much of the male hormone, androgens. 
  2. Low-grade inflammation : White blood cells make substances called low-grade in response to infection or injury leading inflammation. Research shows that polycystic ovaries are triggered by a type of long- term, low-grade inflammation to produce excess androgens.
  3. Heredity : Studies show that there are certain genes associatesd with PCOS. Thus, PCOS can be genetically inherited as well, if there is a family history.
  4. Excess androgen : High levels of androgen is produced by ovaries in cases of PCOS. Having too much androgen interferes with ovulation i.e., not releasing the ovum from the ovaries.

Complications [2]

  1. Infertility
  2. Gestational diabetes or pregnancy-induced high blood pressure
  3. Miscarriage or premature birth
  4. Non-alcoholic steatohepatitis — a severe liver inflammation caused by fat buildup in the liver
  5. Metabolic syndrome — a cluster of conditions including high blood pressure, high blood sugar, and unhealthy cholesterol or triglyceride levels that significantly increase your risk of heart and blood vessel (cardiovascular) disease
  6. Type 2 diabetes or prediabetes
  7. Sleep apnea
  8. Depression, anxiety and eating disorders
  9. Cancer of the uterine lining (endometrial cancer)

Diagnosis

Since PCOS is a syndrome, there are currently no confirmatory tests for its diagnosis. One must go through the basic diagnostic tests such as blood tests, ultrasound scan, and biopsy. To aid the process of its diagnosis, various criteria were proposed, broadly classifying them into three categories. This includes screening through various parameters, out which the presence of at least two of the three criteria is a positive case for PCOS. These criteria include chronic anovulation, hyperandrogenism (clinical or biology), and polycystic ovaries.

Examiners use different criteria for the diagnosis of the syndrome. These are mainly: [3]


  1. National Institute of Child Health and Human Development (NICHD) / National Institute of Health (NIH)
  2. European Society of Human Reproduction and Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM)
  3. Androgen Excess Society AES criteria. 

NICHD/NIH Criteria (1990)

ESHRE/ASRM Rotterdam Criteria (2003)

Androgen Excess Society (AES) Criteria (2006)

Hyperandrogenism

Hyperandrogenism

Hyperandrogenism

Oligo-ovulation/anovulation

Oligo-ovulation/anovulation

Oligo-ovulation/anovulation

Exclusion of other related disorders

Polycystic ovaries

Polycystic ovaries

-

-

Exclusion of other related disorders

 

BIOMARKERS


Figure 2. Cartoon representation of Biomarkers

Biomarkers are molecules of biological relevance found in body fluids and tissues that can indicate standard or abnormal processes or conditions. It is also used to check the body's response to the treatment of a disease or condition. [4] They can be indicators of the body's normal biological processes, pathogen invasion or relating to response to an intervention. Their importance in clinical trials has been well characterised and repeatedly shown to predict relevant clinical outcomes across various treatments and populations correctly. 

Biomarkers confirm the presence of a disease condition or can help identify future comorbidity; therefore, selecting the correct and specific biomarkers are essential in diagnosis. 

Few terms related to biomarkers:

Sensitivity: Sensitivity is the probability that the test results of the biomarker will be positive when the disease is actually present. It is a measure of the true positive that a biomarker can show for a given disease.

Specificity: Specificity is the probability that the test results of the biomarker will be negative when the disease is not present. It is a measure of the true negative that a biomarker can show for a given disease.

FEMALE REPRODUCTIVE SYSTEM

Figure 3. Diagrammatic representation of female reproductive system

Parts of the female reproductive system

. The female reproductive system is composed of 

  1. Ovaries
  2. Fallopian tubes
  3. Uterus
  4. Vagina
  5. Vulva

 Adjacent structures to the uterus consisting of ovaries and fallopian tubes, constitute the adnexa.

Ovaries

  1. Location: Two in number, located on the sides of the uterus.
  2. Ovaries are the site of gametogenesis i.e., the production of gametes and secretion of sex hormones.
  3. There are two prominent regions in the ovaries: 

                  1) Outer cortex: The site where follicles begin to develop.

                  2) Inner Medulla: Enriched with blood vessels and connective tissues.

  4. Each ovary is about the size and shape of an almond. Eggs develop and mature in the ovaries, which are released monthly in the reproductive years.
  5. In premenopausal women, the ovaries produce numerous follicles a month, with one dominant follicle maturing and undergoing ovulation.

 Fallopian Tubes

  1. Fallopian tubes are the major adnexal structures. 
  2. Fallopian tubes allow oocytes to travel from the ovaries into the uterine cavity. 
  3. The part of each tube closest to the ovary contains fimbria: finger-like projections that help move the expelled oocyte further into the tube—the fimbria transitions into the ampulla, the part of the tube with the widest lumen. 
  4. The ampulla is known as the site for fertilisation. The ampulla becomes the isthmus as the lumen narrows and projects towards the uterus.

 Uterus

  1. The uterine region is divided into corpus (body) and cervix
  2. Corpus consists of the fundus, while the inferior portion adjacent to the cervix is called the isthmus/lower uterine segment. 
  3. The uterus is a layered structure primarily composed of three distinct layers: the endometrium, myometrium, and the serosa. 

         1) Endometrium: lines the uterine cavity, and its thickness and structure vary with hormonal stimulation. 

         2) Myometrium: consists of smooth muscle fibers and is the middle and thickest layer of the uterine wall. 

         3) Serosa: The outermost lining of the uterus. [6]

 Vagina

  1. The vagina is a flexible, fibromuscular tubular structure extending from the vestibule to the uterine cervix. The anterior vagina lies adjacent to the posterior bladder wall, while the posterior vagina borders the anterior rectum.

Vulva 

  1. The vulva describes the external female genitalia: labia majora, labia minora, clitoris, vulvar vestibule, urethral meatus, and vaginal orifice.
  2. The labia majora are lateral to the labia minora, fusing anteriorly to make up the mons pubis (a layer overlying the pubic symphysis). The vulvar vestibule is the area medial to the labia minora and is the location of the urethra and vaginal openings.

CYSTS


Figure 4. Cross sectional view of ovary with cysts

What are cysts?

The morphology of cysts includes membranous sac-like pockets that contain fluids, air or other substances. These can vary in size based on various factors such as location, type of cysts, and severity of the disease. If they cause pain or discomfort or are inflated or infected, they must be treated as soon as possible, as it could get life-threatening.



What are Ovarian Cysts?

During ovulation, fluid-filled sacs known as ovarian cysts can form on one or both ovaries, and approximately 20% of women develop at least one pelvic mass in their lifetime. Functional and benign cysts are usually found, which do not need surgical intervention. However, complications such as pelvic pain, cyst rupture, blood loss, and ovarian torsion whose cause can be attributed to ovarian cysts and that require prompt management.

Risk factors for ovarian cyst formation include: [9]

  1. Infertility (problems with conceiving) and issues in pregnancy
  2. Hypothyroidism: Excess of thyroid hormone being released due to an overactive thyroid gland.
  3. Development of fetal ovarian cysts.


What is a polycystic ovary?

Polycysts (poly meaning many; cyst) as seen in the case of Polycystic Ovarian Syndrome, and are formed due to excess androgen production. The ovaries become enlarged and are filled with multiple cysts [10].

APTAMERS


Figure 5. Representation of aptamer folding

What are aptamers?

The term ‘aptamer’ was derived from combining the Latin word ‘aptus’ (to fit) and the Greek word ‘meros’ (part). 

Aptamers are short stretch of single-stranded oligonucleotides that bind specifically to target molecules (in our case, biomarkers of PCOS). They are generally shorter than 40 nucleotides(nts), but the length can vary depending on use and design. The high specificity of aptamers to bind to biomolecules is because of the shape-forming feature of the single-stranded oligonucleotides, making them useful analogues of antibodies. 

Single-stranded RNAs can fold into multiple tertiary structures depending on their sequence, hence giving aptamers an upper edge to be molecular mimics of proteins.

In addition, aptamers are shown to have additional features, such as robustness against both reducing conditions and heat denaturation. They can even be inactivated under physiological conditions by hybridization with antisense oligonucleotides, and thus, design of an antidote molecule is quite simple and easy to make.

LIGHT-UP APTAMERS


Figure 6. Light-up aptamer

This class of aptamers is known to show fluorescence in the presence of a fluorogenic molecule.

Fluorogens are molecules free to rotate about their axis; however, when their movement is restricted, they dissipate the excess energy in the form of fluorescence or heat.

Light-up aptamers use this property of fluorogens to restrict their movement, which is shown to emit fluorescence. They have been used in tagging RNAs, thus providing a simple approach for a protein-free live-cell imaging of RNAs by fluorescence. Being composed of RNA, modulation using different techniques, such as cycles of transcriptions, selection, and reverse transcription, provides a huge advantage over GFP. Several types of well-crafted light-up aptamers include Broccoli, Spinach, Spinach2, and iSpinach.

SELEX


Figure 7. SELEX cycle

Aptamers are generated by an in vitro molecular evolution method known as Systematic Evolution of Ligands by Exponential Enrichment (SELEX). SELEX experiments can be conducted against various target molecules or elements, such as small compounds, proteins, nanoparticles, or live cells. 

The different steps of SELEX include the following:

(1) Incubating single-stranded nucleic acid (DNA, RNA, or modified nucleic acids) pool (library) consisting of 1014–1015 variants of a random 30–100-nts sequence with a target molecule.

(2) Recovering variants with the desired binding with the target molecule. The target-bound sequences are amplified by PCR (DNA SELEX) or reverse transcription PCR (RNA SELEX). The PCR products are utilised for the next selection round as a new sub-pool. After incubation, the unbound sequences are separated from those bound by different methods.

(3) Amplifying the variants using various techniques and sending the aptamer variants for next-gen sequencing (NGS) to obtain the desired aptamers.

CELL-FREE SYSTEM

Cell-free systems are in vitro systems that replicate the cell metabolism outside the cell. The advantage of a cell-free system is that the contents and other factors are under control. Thus it renders a beneficial tool for understanding different biological reactions. In synthetic biology, it is particularly valuable to study the expression of protein from a gene.

Such systems are termed Cell-Free Protein Expression Systems (CFPS). CFPS are of different types:

1) Cell lysate based system - Any organism's cell content after lysing the cell wall (if it exists) and the plasma membrane is a cell lysate based system. Common cell lysate based systems used are the E coli extract system and wheat germ extract, among many others.

2) Protein Using Recombinant Elements (PURE) System -- It is a purified cell lysate based system that contains only enzymes required for transcription and translation, and the other "contaminants" are removed. 

3) In Vitro transcription/translation system -  IVT systems come in kits containing only buffers, enzymes required, and energy sources.

REFERENCES

[1] Polycystic Ovarian Disease - StatPearls - NCBI Bookshelf

[2] Polycystic ovary syndrome (PCOS) - Symptoms and causes - Mayo Clinic

[3] Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

[4] Califf, R. M. (2018). Biomarker definitions and their applications. Experimental Biology and Medicine, 243(3), 213-221. https://doi.org/10.1177/1535370217750088

[5] Unal, I. (2017). Defining an optimal cut-point value in ROC analysis: an alternative approach. Computational and mathematical methods in medicine, 2017.

[6] Physiology, Female Reproduction - StatPearls - NCBI Bookshelf

[7] Manique, M., & Ferreira, A. (2022). Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management. Síndrome do ovário policístico na adolescência: Desafios no diagnóstico e tratamento. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 44(4), 425–433. https://doi.org/10.1055/s-0042-1742292

[8] Stein, I. F., & Leventhal, M. L. (1935). Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29(2), 181-191. https://doi.org/10.1016/S0002-9378(15)30642-6

[9] Ovarian Cyst - StatPearls - NCBI Bookshelf

[10] Ovarian Cyst Article - StatPearls

[11] Adachi, T., & Nakamura, Y. (2019). Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application. Molecules, 24(23). https://doi.org/10.3390/molecules24234229

[12] Garenne, D., Haines, M.C., Romantseva, E.F. et al. Cell-free gene expression. Nat Rev Methods Primers 1, 49 (2021). https://doi.org/10.1038/s43586-021-00046-x


Footer with Sponsors